NLRP3 inflammasome activation and NETs have been associated with a wide range of pathology, including thrombosis, ischemia reperfusion injury, severe COVID-19, acute GVHD, and solid organ graft rejection (36, 38). This evidence concerns the gene NLRP3 and acute graft versus host disease.